PME-1 Modulates Protein Phosphatase 2A Activity to Promote the Malignant Phenotype of Endometrial Cancer Cells von WANDZIOCH, Ewa, PUSEY, Michelle, WERDA, Amy, BAIL, Sophie, BHASKAR, Aishwarya, NESTOR, Mariya, YANG, Jing-Jing, RICE, Lyndi M

Volltext

Ectopic expression of L1CAM ectodomain alters differentiation and motility, but not proliferation, of human neural progenitor cells von Pusey, Michelle A., Pace, Karma, Fascelli, Michele, Linser, Paul J., Steindler, Dennis A., Galileo, Deni S.

Volltext

Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells von Pallai, Rajash, Bhaskar, Aishwarya, Barnett-Bernodat, Natalie, Gallo-Ebert, Christina, Pusey, Michelle, Nickels, Joseph T., Rice, Lyndi M.

Volltext

Identification of pAKT as a pharmacodynamic marker for MER kinase in human melanoma G361 cells von Chen, Yaoyu, Favata, Margaret, Pusey, Michelle, Li, Jun, Lo, Yvonne, Ye, Min, Wynn, Richard, Wang, Xiaozhao, Yao, Wenqing, Chen, Yingnan

Volltext

ALK2 and JAK2 Inhibition for Improved Treatment of Anemia in Myelofibrosis Patients: Preclinical Profile of an ALK2 Inhibitor Zilurgisertib in Combination with Ruxolitinib von Stubbs, Matthew C., Pusey, Michelle, Wen, Xiaoming, Drake, Katherine, Zolotarjova, Nina, Smith, Amanda, Covington, Maryanne, Zhang, Guofeng, Macarrón, Ricardo, Kim, Sunkyu

Volltext

Inhibition of ALK2 with bicyclic pyridyllactams von Witten, Michael R., Wu, Liangxing, Lai, Cheng-Tsung, Kapilashrami, Kanishk, Pusey, Michelle, Gallagher, Karen, Chen, Yaoyu, Yao, Wenqing

Volltext

Characterization of INCB00928, a Potent and Selective ALK2 Inhibitor for the Treatment of Anemia von Chen, Yaoyu, Stubbs, Matthew C., Pusey, Michelle, Wen, Xiaoming, Collins, Robert J., Kapilashrami, Kanishk, Rupar, Mark, Thekkat, Pramod, Lin, Luping, Bowman, Kevin, Yang, Yan-ou, Diamond, Sharon, Yeleswaram, Swamy, Kim, Sunkyu, Koblish, Holly K., Chen, Yingnan, Wee, Susan

Volltext

Abstract 4513: The role of HPK1 in the regulation of T cell function and anti-tumor immune activity von Chen, Yaoyu, Rios-Doria, Jonathan, Pusey, Michelle, Lasky, Kerri, Ye, Min, Thekkat, Pramod, Gallagher, Karen, Stump, Kristine, Conlen, Patricia, Gardiner, Christine, Wang, Hui, Sokolsky, Alexander, Rupar, Mark, Lin, Luping, Behshad, Elham, Covington, Maryanne, Koblish, Holly, Vechorkin, Oleg, Yao, Wenqing, Kim, Sunkyu, Chen, Yingnan

Volltext

Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2 von Nguyen, Minh H., Atasoylu, Onur, Wu, Liangxing, Kapilashrami, Kanishk, Pusey, Michelle, Gallagher, Karen, Lai, Cheng-Tsung, Zhao, Peng, Barbosa, Joseph, Liu, Kai, He, Chunhong, Zhang, Colin, Styduhar, Evan D., Witten, Michael R., Chen, Yaoyu, Lin, Luping, Yang, Yan-ou, Covington, Maryanne, Diamond, Sharon, Yeleswaram, Swamy, Yao, Wenqing

Volltext

Abstract 6274: Preclinical characterization of the BET inhibitor, INCB057643, in combination with ruxolitinib for treatment of myeloproliferative neoplasms (MPN) von Pusey, Michelle, Trivedi, Gaurang, Collins, Bob, Zolotarjova, Nina, Feldman, Pat, Bomber, Monica, Ellis, Jacob, Stengel, Kristy, Timmers, Cynthia, Celik, Hamza, Stubbs, Matt, Jackson, Jeff, Hiebert, Scott, Wee, Susan, Kim, Sunkyu

Volltext

Inhibition of protein methylesterase 1 decreased cancerous phenotypes in endometrial adenocarcinoma cell lines and xenograft tumor models von Pusey, Michelle, Bail, Sophie, Xu, Yan, Buiakova, Olesia, Nestor, Mariya, Yang, Jing-Jing, Rice, Lyndi M.

Volltext

COMBINATION THERAPY COMPRISING AN ALK2 INHIBITOR AND A JAK2 INHIBITOR von CHEN, Ying-Nan Pan, PUSEY, Michelle, CHEN, Yaoyu, STUBBS, Matthew C

Volltext bestellen

Combination therapy comprising an ALK2 inhibitor and a JAK2 inhibitor von Chen, Ying-Nan Pan, Chen, Yaoyu, Pusey, Michelle, Stubbs, Matthew C

Volltext bestellen

COMBINATION THERAPY COMPRISING AN ALK2 INHIBITOR AND A JAK2 INHIBITOR von CHEN, Ying-Nan Pan, PUSEY, Michelle, CHEN, Yaoyu, STUBBS, Matthew C

Volltext bestellen

PME-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition von Rice Lyndi M, Pusey Michelle

Volltext bestellen

Combination therapy comprising an ALK2 inhibitor and a JAK2 inhibitor von CHEN, Ying-Nan Pan, PUSEY, Michelle, CHEN, Yaoyu, STUBBS, Matthew C

Volltext bestellen

COMBINATION THERAPY COMPRISING AN ALK2 INHIBITOR AND A JAK2 INHIBITOR von CHEN, YING-NAN PAN, CHEN, YAOYU, STUBBS, MATTHEW C, PUSEY, MICHELLE

Volltext bestellen

COMBINATION THERAPY COMPRISING AN ALK2 INHIBITOR AND A JAK2 INHIBITOR von CHEN, Ying-Nan Pan, PUSEY, Michelle, CHEN, Yaoyu, STUBBS, Matthew C

Volltext bestellen

COMBINATION THERAPY COMPRISING AN ALK2 INHIBITOR AND A JAK2 INHIBITOR von CHEN, Ying-Nan Pan, PUSEY, Michelle, CHEN, Yaoyu, STUBBS, Matthew C

Volltext bestellen

PME-1 AS A BIOMARKER TO PREDICT AND DIAGNOSE ENDOMETRIAL AND BREAST CANCER AND GENE SILENCING OF PME-1 TO INHIBIT EPITHELIAL TO MESENCHYMAL TRANSITION von PUSEY MICHELLE, RICE LYNDI M

Volltext bestellen